Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
about
Blood CEA levels for detecting recurrent colorectal cancerBlood CEA levels for detecting recurrent colorectal cancerSingle Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and IIColorectal cancer tumour markers and biomarkers: Recent therapeutic advancesDiagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Bone Malignancy: Evidence From a Meta-AnalysisAnti-angiogenic therapies for metastatic colorectal cancer: current and future perspectivesNon-invasive diagnosis of focal liver lesions: an individualized approachAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Quality indicators of clinical cancer care (QC3) in colorectal cancerPromising cytotoxic activity profile of fermented wheat germ extract (AvemarĀ®) in human cancer cell lines.Radiation risks associated with serial imaging in colorectal cancer patients: should we worry?Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressivenessDo the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer.New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsMonitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for RecurrenceSurgical failure after colonic stenting as a bridge to surgery.Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study resultsTumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updatePredictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.A path for diagnosis and therapy of colon cancer: a continuous quality improvementPathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesEstablishment of new predictive markers for distant recurrence of colorectal cancer using lectin microarray analysis.Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinomaCirculating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trialIsolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survivalSurveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer.Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.Bayesian model selection methods in modeling small area colon cancer incidence.Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997-2004.Identification of risk factors for recurrence in high-risk stage II colon cancerIdentification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution.Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery.Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.Role of preoperative CT colonography in patients with colorectal cancer.
P2860
Q24186921-14AC26BD-FB11-41BF-8F21-ADC151EAE704Q24194206-EDDFF65A-7AFF-4CCF-AA00-9B15A89B5210Q26765344-A97F978B-B387-4F27-AD47-1420616C13D7Q26768427-3D1B4940-AA51-4B8E-A51F-57A85B9DD3E3Q26777520-CDDF02A4-2FEA-4E50-B64D-A06D56A8CD8EQ26826817-38D1FD0A-C4EB-4A41-886E-EC094113B029Q26999766-B5C57ACB-69B6-411F-AA1C-A33D76996F95Q27024427-244B2594-41D5-4B5D-901B-972B5DFA270CQ28676969-4C722E98-0AED-4B32-A772-BF689174F3C7Q30318418-BFB7CD27-D9D0-4FD4-A66D-E76C321D2DC8Q30444573-8D79CDE9-843A-445B-89D0-DB47A21295C3Q30975797-741B41BF-7406-43A6-BD3B-A6E51D78EB9CQ33612653-1D3B38CB-C74C-47BE-8AFF-D83A3F654F5AQ33669921-0F55CE63-85A3-44CC-AD18-5D8E76E84F56Q33731804-B20F4CCB-3C41-4299-AF7D-C123C841D37AQ33749725-E672F2A9-0647-4942-B351-253F10A28F5CQ34137400-175CB5B9-301B-47A8-8A63-1C6C769663F1Q34347083-404CB82E-B213-40D7-A7E0-858392DBCAFEQ34441837-DA22EA6B-D267-4546-8754-AD79B4AEDECDQ34620545-65865B8D-F6D7-4B34-9F77-FFF58FF3F3ECQ34785908-669188C0-E73B-4309-87B7-559529AB6D3FQ34974202-DA3CA4C7-C5A2-43DD-ADAA-2C9C72897754Q35084954-3D81C244-E7C7-4A48-9978-021AC11364E8Q35198548-E135F49F-5289-477B-A8CA-03B8F5623A71Q35475513-C8E5DC27-0AFA-4D8A-A00E-A2BFB1B32555Q35859030-B4596CEB-0CDB-49BF-BBE1-5E398ADF796CQ35924171-C3DE98C5-4DA0-43E0-B099-B4E3A763C759Q36001990-8936D3D6-CFC6-40A1-95F6-872CDA5449D2Q36026010-953C1496-C410-4937-A809-1676ABAC288AQ36118410-872F39F6-4CE3-432B-8F15-8BCAC3835354Q36152640-EB33B159-7018-4C01-8B4A-EE8DBC618855Q36393033-8B05D668-ACD7-4E27-AF17-25442D60FB9CQ36429101-9B48F92C-E0E2-4FA6-BCD3-589AFDBAD437Q36663623-673F5F50-BA3A-43A2-9758-5FC6E4B08BF3Q37044768-A31D7F58-B84A-46DC-98EA-46FCAF1803A6Q37211812-A033700E-45A9-48B6-BA81-8EF0FBBC5728Q37308725-7A8E0F37-F208-421D-B1A7-A61C0261BBA2Q37593245-FBC22325-917E-494C-99D2-3C982F1A9574Q37631444-A1DB0109-BB57-4022-9DC0-2748A888A3EBQ37697533-B46E84BD-53C8-45C3-B9DE-E183FA252E63
P2860
Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
description
im Mai 2010 verƶffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2010
@en
wetenschappelijk artikel
@nl
Š½Š°ŃŠŗŠ¾Š²Š° ŃŃŠ°ŃŃŃ, Š¾ŠæŃŠ±Š»ŃŠŗŠ¾Š²Š°Š½Š° Š² ŃŃŠ°Š²Š½Ń 2010
@uk
name
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@en
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@nl
type
label
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@en
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@nl
prefLabel
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@en
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@nl
P2093
P356
P1433
P1476
Primary colon cancer: ESMO Cli ...... juvant treatment and follow-up
@en
P2093
A Cervantes
B Nordlinger
ESMO Guidelines Working Group
G D Beretta
P356
10.1093/ANNONC/MDQ168
P433
Supplement 5
P478
21 Suppl 5
P577
2010-05-01T00:00:00Z